Productively combining proteasome inhibition with the immunotherapy of cancer Thomas Sayers Clinical Implications 09 July 2008 Pages: 857 - 860
DC-SIGN and L-SIGN: the SIGNs for infection Ui-Soon KhooKelvin Y. K. ChanC. L. Steve Lin Review 06 May 2008 Pages: 861 - 874
Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency Morag H. StewartSean C. BendallMickie Bhatia Review 03 June 2008 Pages: 875 - 886
Protein kinase CK2, an important regulator of the inflammatory response? Nishi N. SinghDipak P. Ramji Review 25 April 2008 Pages: 887 - 897
Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination Chih-Wen TsengArchana MonieT.-C. Wu Original Paper 10 June 2008 Pages: 899 - 908
Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells Edwin BremerMarco de BruynWijnand Helfrich Original Article Open access 27 May 2008 Pages: 909 - 924
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors Martin A. StorrCatherine M. KeenanKeith A. Sharkey Original Article 21 May 2008 Pages: 925 - 936
Human rheumatoid synoviocytes express functional P2X7 receptors Francesca CaporaliPier Leopoldo CapecchiFranco Laghi Pasini Original Article 11 June 2008 Pages: 937 - 949
Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita Alina SesarmanAna Gabriela SitaruCassian Sitaru Original Article 10 June 2008 Pages: 951 - 959
ADAM12: a potential target for the treatment of chronic wounds Asheesh HarshaOlivera StojadinovicMarjana Tomic-Canic Original Article 05 July 2008 Pages: 961 - 969